Gastroesophageal reflux disease (GERD) continues to be among the most common
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …

Background and Aims Transoral incisionless fundoplication (TIF) using the EsophyX device
(EndoGastric Solutions, Inc, Redmond, Wash, USA) is a minimally invasive endoscopic …

Background Gastroesophageal reflux disease (GERD) is one of the most common diseases
in North America and globally. The aim of this guideline is to provide evidence-based …

Objectives Anti‐reflux mucosectomy (ARMS) and anti‐reflux mucosal ablation (ARMA) were
developed as interventions for proton pump inhibitor (PPI)‐refractory/‐dependent …

Background The purpose of this study was to review the current management of gastro-
oesophageal reflux disease (GORD), including treatment costs, safety profile and …

Abstract Background and Aim Anti‐reflux mucosal ablation (ARMA) is an emerging
endoscopic treatment aimed at enhancing the gastroesophageal junction flap valve. This …

Background: Idiopathic pulmonary fibrosis (IPF) is a rare and severe disease with a median
survival of∼ 3 years. Several risk factors have been identified, such as age, genetic …

Background Revision of a failed laparoscopic fundoplication carries higher risk of
complication and lower chance of success compared to the original surgery. Transoral …

Gastroesophageal reflux disease (GERD) is a chronic disease on a spectrum that has an
array of management options ranging from lifestyle changes, acid suppressive therapy to …

Proton pump inhibitors (PPIs) are the main treatment recommended and used for gastro-
esophageal reflux disease (GERD). However, they fail to control symptoms in a substantial …